- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
Last Updated on 09/02/2026 by Sarah Sarsby
The NHS Supply Chain Supplier Webinar held in February 2026 provided suppliers with updates on several initiatives shaping procurement and supplier engagement across the health system. Topics included the NHS England Cyber Charter, the Supplier Performance Dashboard, developments in value-based healthcare, and a brief update on the NHS Core List.
Rachel Million, from the NHS Supply Chain Cyber Team, outlined the latest developments in NHS England’s Cyber Improvement Programme, which is driving higher standards of cyber resilience across the healthcare supply chain. Under the Cyber Charter, suppliers will be contacted by NHS England to discuss their cyber security controls and may be asked to provide evidence of compliance. Further detail is set out in NHS England’s open letter on the Cyber Improvement Programme (the Cyber Charter).
The programme aims to reduce the likelihood and impact of cyber incidents that could affect patient care. Suppliers were advised to review their information security measures, confirm certification status where applicable, and ensure they can provide evidence when requested. NHS Supply Chain noted that cyber resilience is now considered a core component of supply chain assurance.
Kate Mokrysz, Supplier Performance and Risk Manager, discussed the Supplier Performance Dashboard, which enables suppliers and NHS Supply Chain to view and compare performance data across cost, quality, service, and sustainability.
Current metrics include service levels, delivery performance, demand management, and data conformance. Further measures are expected to be added over the coming months, including product regulatory compliance, patient safety complaints, sustainability indicators, and information relating to supplier innovation pipelines.
Suppliers who wish to access their own performance data can request dashboard access via their NHS Supply Chain category contact.
Oliver Booth, Care Pathway Specialist (Midlands), discussed NHS Supply Chain’s ongoing work on value-based healthcare, which focuses on improving outcomes, efficiency, and total cost of care rather than unit price alone.
Suppliers were encouraged to bring forward solutions supported by robust evidence, including real-world data, patient experience, and economic modelling aligned to NHS priorities. Oliver highlighted NHS Supply Chain’s existing value-based healthcare portfolio, which includes case studies demonstrating measurable clinical and system benefits across stages such as pilot implementation, pathway optimisation, financial modelling, and benefits realisation.
NHS Supply Chain is continuing to build the next wave of value-based healthcare opportunities and encouraged suppliers to engage early and share strong evidence packs.
Fay Allen, Innovation Specialist, outlined a formalised Innovation Marketing Playbook designed to bring greater consistency and clarity to how innovative products are communicated within NHS Supply Chain.
A central element of the framework is the Innovation Brief, a structured document intended to present innovations in a clear, evidence-led format. Each brief includes an executive summary, classification of the innovation, key opportunity highlights, relevant clinical or economic evidence, and practical information such as ordering details and supporting guidance.
By standardising how innovations are presented, NHS Supply Chain aims to make it easier for NHS organisations to identify, assess, and adopt new technologies. For BHTA member suppliers, this approach may provide a clearer route for showcasing evidence-based products that align with value-based healthcare objectives.
Hamish Makanji, Head of Category – Medical and Surgical Consumables, provided a brief update on the NHS Core List, which aims to simplify procurement for standardised, high-volume consumables through a nationally coordinated route.
From the information presented, the Core List is intended for standardised consumables rather than specialist or bespoke clinical solutions. As many BHTA products, including assistive technology, rehabilitation, mobility, and complex care devices, are tailored to individual patient needs, they are less likely to fall within scope in the near term. While the Core List will continue to expand during 2026, its relevance to most BHTA members is expected to remain limited.
BHTA will continue to monitor NHS Supply Chain developments and share relevant updates to support members in understanding changes across the procurement landscape.
